UCO Bank
UCOBANKUCO Bank's earnings have outrun its stock. EPS grew +40.7% in a year against a −10.2% price move.
The sharpest disagreement: annual EPS moved +40.7% against a −10.2% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (94 weeks in) while the P/BV sits at the 18th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +15.6% year on year, and gross NPA has eased to 2.41%. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
UCO Bank trades at ₹26.2, in a downtrend and 94 weeks into that stage. That is −6.5% against its own 200-day average. It sits at 27% of a 52-week range of ₹24 to ₹33. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is in a downtrend — week 94 of stage 4, confirmed. At ₹26.2 it trades −6.5% versus its 200-day average and sits at 27% of its 52-week range (₹24–₹33).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved −16% while the NIFTY 500 moved +282% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
UCO Bank trades at 1.1× P/BV, near the bottom of its own range — cheaper only 18% of the time. Its long-run median P/BV is 1.3×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 1.1× is near the bottom of its own range — cheaper only 18% of the time, against a long-run median of 1.3× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 8% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
Why the multiple sits where it does: over the past year book value grew while the price moved −10.2% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 3y, of the −3.1%/yr price move, ~+2.5%/yr came from book-value growth and ~−5.6 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
UCO Bank reads as mixed on its fundamental arc. Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +95.8% at its peak to +12.5% but is still expanding, ROE holding at 7.9%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +14.7% | +18.7% | +10.6% | +2.6% |
| Profit | +47.6% | +36.8% | — | +8.0% |
| EPS | +40.7% | +34.5% | — | −15.5% |
| Share price | −10.2% | −3.1% | +13.7% | −5.1% |
4-Factor Sector Score
45.6/100 — rank 11 of 13 in Banks - PSU · 96% evidence confidence
UCO Bank scores 45.6 out of 100 against the 13 companies it is compared with in Banks - PSU, ranking 11. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 17.7 + 7.2 + 11.7 + 9 = 45.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
UCO Bank reported ₹6,652 Cr of income in the Dec 25 quarter, +6.9% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 2.6% a year. The last full year, FY25, came in at ₹25,067 Cr. The last four reported quarters add to ₹26,370 Cr.
FY25 revenue came in at ₹25,067 Cr (+14.7% on the year), capping 10 years at 2.6% compound. The latest quarter (Dec 25) printed ₹6,652 Cr, +6.9% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +9.1% growth against the decade's 2.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +9.0% over the last 4 quarters against +12.1%/yr over the last 8 — rolling over; TTM profit +12.5% vs +24.8%/yr — rolling over.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
UCO Bank's net margin is 11.1% in the Dec 25 quarter, +0.8 percentage points against the same quarter a year ago. Across 12 fiscal years the net margin has ranged −31.6% to 10.3%. The current quarter is running above every full year in that window.
The latest quarter's net margin is 11.1%, +0.8 pp against the same quarter a year ago. Across 12 fiscal years the net margin has ranged −31.6%–10.3%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
UCO Bank earned ₹740 Cr of net profit in the Dec 25 quarter, +15.6% year on year. It is the 7th consecutive quarter of growth. Full-year FY25 profit was ₹2,468 Cr. The 10-year compound rate is 8.0%. That is 11.1% of the quarter's revenue. The same quarter a year earlier earned ₹640 Cr.
Dec 25 profit was ₹740 Cr, +15.6% year on year — the 7th consecutive quarter of growth. On the full year, FY25 printed ₹2,468 Cr (+47.6%), and the 10-year compound rate is 8.0%.
Why profit moved: revenue contributed +6.9% and the margin +0.8 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +12.7% vs revenue +9.1%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
UCO Bank's gross NPA is 2.41% of the loan book in Dec 25, down from 2.91% a year ago. Net of provisions already set aside, 0.36% remains. That is the 11th straight quarter of improvement. Across the 12 quarters held here the book has ranged 2.41% to 4.78%. Falling NPAs are a loan book healing; rising NPAs are damage arriving.
Dec 25: gross NPA at 2.41% and net NPA at 0.36%, against 2.91% / 0.63% a year ago. Over the 12 quarters we hold, the book's worst reading was 4.78% and its best is 2.41% — which is the current print. The ladder has now improved for 11 consecutive quarters.
The synthesis: profit growth at a bank is only as good as the book behind it, and this book is healing on a multi-quarter streak. A note on depth: quarterly provisioning detail is not in our numbers yet, so this ladder reads levels and trend, not the cost of the cleanup.
Why the ladder moved: recoveries, write-offs and slippages each play a part, and that split sits below what we hold — the numbers show the healing; the driver mix does not travel with them.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
UCO Bank's revenue grew +14.7% in FY25 to ₹25,067 Cr, so the book is growing. The latest quarter ran +6.9% year on year. The net margin on that income is 11.1%, +0.8 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY25 revenue was ₹25,067 Cr, +14.7% on the year, and the latest quarter ran +6.9% year on year. The net margin on that revenue is 11.1% this quarter (+0.8 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
UCO Bank earns a return on equity of 8% in FY25. Its trough over the ladder below was −32% in FY18. On the asset side every ₹100 of the balance sheet earned about ₹0.73, which is the return before leverage is applied.
FY25 ROE came in at 8%, recovered from a FY18 trough of −32%. On assets, the latest reading is about 0.73% — every ₹100 the bank deploys earns roughly ₹0.73 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why ROE moved: profit compounded 8.0% a year over 10 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 4.4 points of UCO Bank over 8 quarters, the biggest move on the register. That takes promoters to 91.0% of the company. Domestic institutions moved +3.0 points over the same window, to 4.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −4.4 points over 8 quarters to 91.0%; Domestic institutions: +3.0 points over 8 quarters to 4.3%; Foreign institutions: +0.0 points over 8 quarters to 0.1%.
🚨 Why the register moved: promoters drove it (−4.4 points), absorbed on the other side by domestic institutions (+3.0 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
UCO Bank: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Bank of MaharashtraMAHABANK | 77.5/100Favorable setup100% evidence | FADING | 29.3/35 Income 15.8% · PAT 31% 100% evidence | 24.3/25 ROA 2% · ROE 22.6% · GNPA 1.4% 100% evidence | 9.9/20 P/BV 1.71× · P/BV÷ROE 0.08 100% evidence | 14.0/20 RS sector 20.6% · RS bench 16.2% · 1Y 39.9%10 of 12 weeks ahead 100% evidence |
| Exact sum: 29.3 + 24.3 + 9.9 + 14 = 77.5 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Indian Overseas BankIOB | 66.3/100Favorable setup87% evidence | ASLEEP | 31.5/35 Income 14.8% · PAT 51.8% 100% evidence | 17.0/25 ROA 1.4% · ROE 15.6% · GNPA — 72% evidence | 12.7/20 P/BV 1.68× · P/BV÷ROE 0.11 100% evidence | 5.1/20 RS sector -11.8% · RS bench -7.1% · 1Y -11.8%0 of 10 weeks ahead 70% evidence |
| Exact sum: 31.5 + 17 + 12.7 + 5.1 = 66.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -11.8% and the one-year return is -11.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Union Bank of IndiaUNIONBANK | 60.6/100Mixed-positive evidence93% evidence | TURNING | 11.6/35 Income -1.3% · PAT 9.7% 100% evidence | 17.4/25 ROA 1.4% · ROE 15.7% · GNPA — 72% evidence | 13.5/20 P/BV 0.93× · P/BV÷ROE 0.06 100% evidence | 18.1/20 RS sector 8.8% · RS bench 4.6% · 1Y 25.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.6 + 17.4 + 13.5 + 18.1 = 60.6 · Decision use: Price leads the evidence: RS versus the benchmark is 4.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Indian BankINDIANB | 58.9/100Mixed-positive evidence100% evidence | ASLEEP | 20.8/35 Income 9.5% · PAT 16.6% 100% evidence | 17.4/25 ROA 1.3% · ROE 15.4% · GNPA 1.9% 100% evidence | 10.1/20 P/BV 1.34× · P/BV÷ROE 0.09 100% evidence | 10.6/20 RS sector 3.4% · RS bench -0.5% · 1Y 31.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 17.4 + 10.1 + 10.6 = 58.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Bank of IndiaBANKINDIA | 56.3/100Mixed-positive evidence93% evidence | ASLEEP | 21.9/35 Income 6.2% · PAT 24.1% 100% evidence | 10.2/25 ROA 1% · ROE 12.4% · GNPA — 72% evidence | 15.1/20 P/BV 0.69× · P/BV÷ROE 0.06 100% evidence | 9.1/20 RS sector 0.1% · RS bench -3.8% · 1Y 21.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.9 + 10.2 + 15.1 + 9.1 = 56.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Punjab National BankPNB | 54.9/100Mixed-positive evidence82% evidence | TURNING | 20.1/35 Income 3.4% · PAT 32.3% 86% evidence | 12.1/25 ROA 1.1% · ROE 13% · GNPA — 72% evidence | 14.3/20 P/BV 0.83× · P/BV÷ROE 0.06 100% evidence | 8.4/20 RS sector -3.8% · RS bench -2.5% · 1Y 4%0 of 10 weeks ahead 70% evidence |
| Exact sum: 20.1 + 12.1 + 14.3 + 8.4 = 54.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Canara BankCANBK | 52.9/100Mixed-positive evidence94% evidence | ASLEEP | 12.4/35 Income 3.1% · PAT 17.8% 100% evidence | 13.4/25 ROA 0.6% · ROE 16.1% · GNPA 1.6% 100% evidence | 14.7/20 P/BV 0.92× · P/BV÷ROE 0.06 100% evidence | 12.4/20 RS sector 7.7% · RS bench -8.3% · 1Y 12.8%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.4 + 13.4 + 14.7 + 12.4 = 52.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 8State Bank of IndiaSBIN | 49.5/100Mixed-negative evidence80% evidence | ASLEEP | 13.2/35 Income 5% · PAT 7.6% 67% evidence | 13.9/25 ROA 1.1% · ROE 15.4% · GNPA — 68% evidence | 10.2/20 P/BV 1.59× · P/BV÷ROE 0.1 100% evidence | 12.2/20 RS sector 6.3% · RS bench 2.3% · 1Y 27.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 13.9 + 10.2 + 12.2 = 49.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Bank of BarodaBANKBARODA | 48.9/100Mixed-negative evidence87% evidence | ASLEEP | 9.2/35 Income 4.9% · PAT -6.3% 100% evidence | 12.8/25 ROA 1.2% · ROE 12.7% · GNPA — 72% evidence | 16.4/20 P/BV 0.75× · P/BV÷ROE 0.06 100% evidence | 10.5/20 RS sector 4.7% · RS bench -12.1% · 1Y -0.3%0 of 9 weeks ahead 70% evidence |
| Exact sum: 9.2 + 12.8 + 16.4 + 10.5 = 48.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 10Punjab & Sind BankPSB | 48.5/100Mixed-negative evidence94% evidence | ASLEEP | 24.4/35 Income 4.6% · PAT 25.4% 100% evidence | 8.5/25 ROA 1% · ROE 9.6% · GNPA 2.2% 100% evidence | 10.1/20 P/BV 1.13× · P/BV÷ROE 0.12 70% evidence | 5.5/20 RS sector -11.7% · RS bench -14.5% · 1Y -22.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 24.4 + 8.5 + 10.1 + 5.5 = 48.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -11.7% and the one-year return is -22.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 11UCO Bankthis pageUCOBANK | 45.6/100Mixed-negative evidence96% evidence | ASLEEP | 17.7/35 Income 9.1% · PAT 12.5% 88% evidence | 7.2/25 ROA 0.8% · ROE 8.5% · GNPA 2.4% 100% evidence | 11.7/20 P/BV 1.07× · P/BV÷ROE 0.13 100% evidence | 9.0/20 RS sector -5.1% · RS bench -8.3% · 1Y -13.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 7.2 + 11.7 + 9 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12IDBI Bank LtdIDBI | 44.0/100Mixed-negative evidence87% evidence | TURNING | 10.6/35 Income 0.9% · PAT 17.7% 100% evidence | 17.3/25 ROA 1.8% · ROE 14.1% · GNPA — 72% evidence | 12.3/20 P/BV 1.31× · P/BV÷ROE 0.09 100% evidence | 3.8/20 RS sector -30.5% · RS bench -8.7% · 1Y -10.2%4 of 10 weeks ahead 70% evidence |
| Exact sum: 10.6 + 17.3 + 12.3 + 3.8 = 44 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Central Bank of IndiaCENTRALBK | 38.1/100Mixed-negative evidence94% evidence | ASLEEP | 9.7/35 Income 9.4% · PAT 6.8% 100% evidence | 6.2/25 ROA 0.6% · ROE 11.9% · GNPA 2.6% 100% evidence | 17.7/20 P/BV 0.69× · P/BV÷ROE 0.06 100% evidence | 4.5/20 RS sector -9.1% · RS bench -14.5% · 1Y -16%0 of 10 weeks ahead 70% evidence |
| Exact sum: 9.7 + 6.2 + 17.7 + 4.5 = 38.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is UCO Bank's share price today?
UCO Bank trades at ₹26.2, −10.2% over the past year. The company is valued at ₹32,816 Cr. The stock sits at 27% of its 52-week range of ₹24–₹33, −6.5% versus its 200-day average. On the tape, the price is in a downtrend, 94 weeks in. — as of 31 July 2026.
What were UCO Bank's latest quarterly results?
UCO Bank reported total income of ₹6,652 Cr and net profit of ₹740 Cr for the Dec 25 quarter. Income rose 6.9% and profit rose 15.6% year on year. Earnings per share were ₹0.59. The net margin was 11.1%, 0.8 pp higher than a year earlier. — as of 31 July 2026.
What is UCO Bank's revenue?
UCO Bank reported revenue of ₹6,652 Cr in the Dec 25 quarter, +6.9% year on year. For the full FY25 fiscal year, revenue was ₹25,067 Cr (+14.7%). Over the last 10 years revenue compounded at 2.6% a year. — as of 31 July 2026.
What is UCO Bank's profit?
UCO Bank earned ₹740 Cr of net profit in the Dec 25 quarter, +15.6% year on year — the 7th straight quarter of growth. Full-year FY25 profit was ₹2,468 Cr. The net margin ran 11.1% in the latest quarter. — as of 31 July 2026.
What is UCO Bank's market cap?
UCO Bank's market capitalisation is ₹32,816 Cr at a share price of ₹26.2. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is UCO Bank's P/BV ratio?
UCO Bank trades at a P/BV of 1.1×, at the 18th percentile of its own 11-year range, against a long-run median of 1.3×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does UCO Bank pay a dividend?
Yes — UCO Bank's dividend payout was 20% of profit in FY25, and it recorded a payout in 4 of its last 12 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is UCO Bank overvalued?
On its own history, UCO Bank looks cheap against its own history: its P/BV of 1.1× has been cheaper only 18% of the time in 11 years (long-run median 1.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is UCO Bank growing?
Yes — UCO Bank is growing: latest-quarter revenue +6.9% year on year, profit +15.6%, and the the net margin +0.8 pp at 11.1%. The 10-year compound rates are 2.6% (revenue) and 8.0% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is UCO Bank performing?
UCO Bank is in a downtrend, 94 weeks in. Its latest quarter's income rose 6.9% and profit rose 15.6% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is UCO Bank in?
Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +95.8% at its peak to +12.5% but is still expanding, ROE holding at 7.9%. The read comes from the last 12 quarters of growth (revenue growth +9.0% latest, profit growth +12.5% latest, eps growth +6.6% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is UCO Bank in an uptrend?
No — the price is in a downtrend (week 94 of stage 4), trading −6.5% versus its 200-day average and at 27% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is UCO Bank beating the market?
Not lately — on a trailing-13-week view UCO Bank is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved −16% against the NIFTY 500's +282% — behind the index over the full window. — as of 31 July 2026.
Will UCO Bank's share price go up?
This page publishes no price forecast for UCO Bank. What it measures instead: the share price is ₹26.2, the price is in a downtrend 94 weeks in. Its P/BV of 1.1× sits at the 18th percentile of its own 11-year range. Direction is not something this site claims to know. — as of 31 July 2026.
Who owns UCO Bank?
Promoters hold 91.0% of UCO Bank, foreign institutions 0.1%, domestic institutions 4.3% and the public 4.7% (latest quarter). The biggest move on the register over the last two years: Promoters cut 4.4 points over 8 quarters. — as of 31 July 2026.
Is UCO Bank's loan book healthy?
Gross NPA is 2.41% of UCO Bank's loan book, down from 2.91% a year ago — the 11th straight quarter of improvement, and net NPA stands at 0.36%. Falling NPAs are a loan book healing; rising NPAs are damage arriving — as of 31 July 2026.
Where is UCO Bank in its business cycle?
UCO Bank's FY25 net margin was 9.8%, against a 12-year band of −31.6%–10.3%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 11.1%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the UCO Bank story?
The sharpest disagreement: annual EPS moved +40.7% against a −10.2% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is UCO Bank a stock worth studying right now?
This is not investment advice. The machine read: UCO Bank's earnings have outrun its stock. EPS grew +40.7% in a year against a −10.2% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.